Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites

View through CrossRef
Abstract Background We previously reported the effect of contraception on cervical tenofovir concentrations in Ugandan women with human immunodeficiency virus (HIV). Here we explored the role of cervicovaginal cytokines and drug metabolizing enzymes and transporters (DMETs) to elucidate female genital tract (FGT) drug disposition in a Ugandan cohort. Methods Cervicovaginal fluid and cervical biopsies were collected from Ugandan women with HIV receiving tenofovir/lamivudine-based therapy and intramuscular depot medroxyprogesterone acetate (n = 25), copper intrauterine device (cuIUD; n = 12), or condoms (n = 13) as contraception. Cytokines were measured in cervicovaginal fluid (CVF). Ectocervical tenofovir diphosphate (TFVdp), lamivudine triphosphate (3TCtp), and deoxyadenosine triphosphate (dATP)/deoxycytidine triphosphate (dCTP) concentrations and immune marker/DMET gene expression were measured in cervical biopsies. Results Cervical 3TCtp was not correlated with any CVF cytokines. Cervical TFVdp was correlated with IL-10, IL-7, and IL-17 in CVF. CCR5 mRNA expression in cervical biopsies was higher in cuIUD users versus condom users. Using multivariable linear regression, CVF IL-17, tissue dATP, plasma estradiol, and plasma tenofovir were all significant predictors of cervical TFVdp. Tissue dCTP and plasma lamivudine were significant predictors of cervical 3TCtp. Conclusions TFVdp concentrations in cervix appear to be influenced by local inflammation. In contrast, 3TCtp FGT exposure was not affected by genital inflammation or DMETs. CuIUD users have more immune cells present, which may in turn influence local TFVdp disposition. Main Finding We investigated changes in tenofovir diphosphate and lamivudine triphosphate due to the microbiome and inflammation. While lamivudine triphosphate was not affected by either, tenofovir diphosphate appeared to be affected by local inflammation. Specifically, Th17 cells may influence tenofovir disposition.
Title: Female Genital Tract Host Factors and Tenofovir and Lamivudine Active Metabolites
Description:
Abstract Background We previously reported the effect of contraception on cervical tenofovir concentrations in Ugandan women with human immunodeficiency virus (HIV).
Here we explored the role of cervicovaginal cytokines and drug metabolizing enzymes and transporters (DMETs) to elucidate female genital tract (FGT) drug disposition in a Ugandan cohort.
Methods Cervicovaginal fluid and cervical biopsies were collected from Ugandan women with HIV receiving tenofovir/lamivudine-based therapy and intramuscular depot medroxyprogesterone acetate (n = 25), copper intrauterine device (cuIUD; n = 12), or condoms (n = 13) as contraception.
Cytokines were measured in cervicovaginal fluid (CVF).
Ectocervical tenofovir diphosphate (TFVdp), lamivudine triphosphate (3TCtp), and deoxyadenosine triphosphate (dATP)/deoxycytidine triphosphate (dCTP) concentrations and immune marker/DMET gene expression were measured in cervical biopsies.
Results Cervical 3TCtp was not correlated with any CVF cytokines.
Cervical TFVdp was correlated with IL-10, IL-7, and IL-17 in CVF.
CCR5 mRNA expression in cervical biopsies was higher in cuIUD users versus condom users.
Using multivariable linear regression, CVF IL-17, tissue dATP, plasma estradiol, and plasma tenofovir were all significant predictors of cervical TFVdp.
Tissue dCTP and plasma lamivudine were significant predictors of cervical 3TCtp.
Conclusions TFVdp concentrations in cervix appear to be influenced by local inflammation.
In contrast, 3TCtp FGT exposure was not affected by genital inflammation or DMETs.
CuIUD users have more immune cells present, which may in turn influence local TFVdp disposition.
Main Finding We investigated changes in tenofovir diphosphate and lamivudine triphosphate due to the microbiome and inflammation.
While lamivudine triphosphate was not affected by either, tenofovir diphosphate appeared to be affected by local inflammation.
Specifically, Th17 cells may influence tenofovir disposition.

Related Results

Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Background: Tenofovir disoproxil fumarate is a prodrug of tenofovir diphosphate that exposes patients to renal toxicity over the long term. Tenofovir alafenamide, a new prodrug, no...
Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers
Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers
ABSTRACT Tenofovir disoproxil fumarate (tenofovir DF) was studied in combination with rifampin in 24 healthy subjects in a multiple-dose, open-label, single-...
Tenofovir Overdosage-A Rarely Reported Phenomenon in Literature
Tenofovir Overdosage-A Rarely Reported Phenomenon in Literature
Introduction: Hepatitis B virus (HBV) has infected affected thirty three percent of the world population, two billion have been infected worldwide and out of them, 350 million suff...
Long-term dynamics of pesticide metabolites in soil and aquifers
Long-term dynamics of pesticide metabolites in soil and aquifers
Groundwater is one of the most important resources for drinking water, and has to be protected from the input of persistent substances. Nevertheless, pesticides and especially thei...

Back to Top